Johnson & Johnson

163.00+2.56+1.60%Vol 8.09M1Y Perf 12.03%
Feb 24th, 2021 15:56 DELAYED
BID162.98 ASK163.00
Open162.40 Previous Close160.44
Pre-Market162.40 After-Market-
 1.96 1.22%  - -
Target Price
183.08 
Analyst Rating
Moderate Buy 1.56
Potential %
12.10 
Finscreener Ranking
★★+     48.29
Insiders Trans % 3/6/12 mo.
-100/-100/-60 
Value Ranking
★★+     50.36
Insiders Value % 3/6/12 mo.
-100/-100/-99 
Growth Ranking
★★★★+     63.32
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-99 
Income Ranking
★★★     46.04
Market Cap429.10B 
Earnings Rating
Buy
Price Range Ratio 52W %
83.49 
Earnings Date
13th Apr 2021

Today's Price Range

160.92164.39

52W Range

109.16173.65

5 Year PE Ratio Range

17.20310.40

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Buy
Performance
1 Week
-3.15%
1 Month
-1.90%
3 Months
11.52%
6 Months
6.18%
1 Year
12.03%
3 Years
21.53%
5 Years
52.86%
10 Years
212.04%

TickerPriceChg.Chg.%
JNJ163.002.56001.60
AAPL125.31-0.5500-0.44
GOOG2 099.7328.87001.39
MSFT234.731.46000.63
XOM56.751.70003.09
WFC38.291.15003.10
FB264.54-1.3100-0.49
GE13.110.52004.13
JPM153.242.63001.75
Financial StrengthValueIndustryS&P 500US Markets
1.20
1.50
0.34
0.59
139.20
Leverage Ratio 2.60
ProfitabilityValueIndustryS&P 500US Markets
65.60
23.80
32.60
22.80
18.01
RevenueValueIndustryS&P 500US Markets
82.58B
31.37
2.40
3.73
DividendsValueIndustryS&P 500US Markets
2.50
4.04
6.20
6.14
Payout ratio61.00
Earnings HistoryEstimateReportedSurprise %
Q04 20201.811.862.76
Q03 20201.992.2010.55
Q02 20201.501.6711.33
Q01 20202.032.3013.30
Q04 20191.861.881.08
Q03 20192.002.126.00
Q02 20192.422.586.61
Q01 20192.032.103.45
Earnings Per EndEstimateRevision %Trend
3/2021 QR2.303.60Positive
6/2021 QR2.307.98Positive
12/2021 FY9.485.33Positive
12/2022 FY10.174.74Positive
Next Report Date13th Apr 2021
Estimated EPS Next Report2.30
Estimates Count6
EPS Growth Next 5 Years %7.70
Volume Overview
Volume8.18M
Shares Outstanding2.63B
Trades Count131.60K
Dollar Volume1.72B
Avg. Volume8.46M
Avg. Weekly Volume6.75M
Avg. Monthly Volume8.29M
Avg. Quarterly Volume8.03M

Johnson & Johnson (NYSE: JNJ) stock closed at 160.44 per share at the end of the most recent trading day (a -0.88% change compared to the prior day closing price) with a volume of 7.04M shares and market capitalization of 428.76B. Is a component of S&P 500, Dow Jones 30, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 135100 people. Johnson & Johnson CEO is Alex Gorsky.

The one-year performance of Johnson & Johnson stock is 12.03%, while year-to-date (YTD) performance is 1.94%. JNJ stock has a five-year performance of 52.86%. Its 52-week range is between 109.16 and 173.65, which gives JNJ stock a 52-week price range ratio of 83.28%

Johnson & Johnson currently has a PE ratio of 30.10, a price-to-book (PB) ratio of 6.77, a price-to-sale (PS) ratio of 5.16, a price to cashflow ratio of 20.50, a PEG ratio of 2.32, a ROA of 8.66%, a ROC of 17.93% and a ROE of 22.97%. The company’s profit margin is 18.01%, its EBITDA margin is 32.60%, and its revenue ttm is $82.58 Billion , which makes it $31.37 revenue per share.

Of the last four earnings reports from Johnson & Johnson, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $2.30 for the next earnings report. Johnson & Johnson’s next earnings report date is 13th Apr 2021.

The consensus rating of Wall Street analysts for Johnson & Johnson is Moderate Buy (1.56), with a target price of $183.08, which is +12.10% compared to the current price. The earnings rating for Johnson & Johnson stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Johnson & Johnson has a dividend yield of 2.50% with a dividend per share of $4.04 and a payout ratio of 61.00%.

Johnson & Johnson has a Neutral technical analysis rating based on Technical Indicators (ADX : 10.30, ATR14 : 4.19, CCI20 : -107.93, Chaikin Money Flow : -0.23, MACD : 0.73, Money Flow Index : 48.03, ROC : -2.44, RSI : 43.44, STOCH (14,3) : 10.39, STOCH RSI : 0.00, UO : 46.16, Williams %R : -89.61), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Johnson & Johnson in the last 12-months were: Ashley McEvoy (Sold 29 000 shares of value $4 276 630 ), Kathryn E. Wengel (Option Excercise at a value of $1 027 323), Kathryn E. Wengel (Sold 16 115 shares of value $2 473 937 ), Michael E. Sneed (Option Excercise at a value of $3 399 976), Michael E. Sneed (Sold 54 662 shares of value $8 359 459 ), William D. Perez (Buy at a value of $63 843)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
11 (68.75 %)
11 (68.75 %)
10 (66.67 %)
Moderate Buy
1 (6.25 %)
1 (6.25 %)
1 (6.67 %)
Hold
4 (25.00 %)
4 (25.00 %)
4 (26.67 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
1.56
Moderate Buy
1.56
Moderate Buy
1.60

Johnson & Johnson

Johnson & Johnson is the world's largest and most diverse healthcare company. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. Geographically, close to half of total revenue is generated in the United States.

CEO: Alex Gorsky

Teplephone: +1 732 524-0400

Address: One Johnson & Johnson Plaza, New Brunswick 08933, NJ, USA

Number of employees: 135 100

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

75%25%

Bearish Bullish

56%44%

Bearish Bullish

52%48%

Bearish Bullish

51%49%

News

Stocktwits